-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QgwJJ6KuD6GaG4fyMn079VrfRJJjX3DTMHwwCMYeNJbSNfVZvrICXfUGuVQGqqm7 SvluWcbgRp8d6sP/G2kc6A== 0001005477-04-002643.txt : 20040714 0001005477-04-002643.hdr.sgml : 20040714 20040714154328 ACCESSION NUMBER: 0001005477-04-002643 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040701 FILED AS OF DATE: 20040714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DIXON ROSINA B CENTRAL INDEX KEY: 0001007932 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 04913841 BUSINESS ADDRESS: STREET 1: 43 STREET 2: 43 OLD WOOD ROAD CITY: BERNARDSVILLE STATE: NJ ZIP: 07924 MAIL ADDRESS: STREET 1: 43 OLD WOOD ROAD CITY: BERNARDSVILLE STATE: NJ ZIP: 07924 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 7329804500 MAIL ADDRESS: STREET 1: C/O DORSEY & WHITNEY LLP STREET 2: 250 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10177 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4/A 1 edgar123.xml AMENDMENT TO FORM 4 X0202 4/A 2004-07-01 2004-07-06 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001007932 DIXON ROSINA B C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807 1 0 0 0 Common Stock 2004-07-01 4 A 0 1989 0 A 39594 D Common Stock 500 I By Husband Common Stock 100 I By Son This filing is an amendment to the Form 4 filed on behalf of Ms. Dixon on July 6, 2004 (the "Original Form 4"). The sole purpose of this amendment is to attach a power of attorney. The information reported on Table I of this amendment, including the footnotes below, is the same as the information reported on Table I of the Original Form 4 and is being reported again solely to gain access to the EDGAR system. Restricted stock granted by Enzon Pharmaceuticals, Inc. ("Enzon") pursuant to Enzon's 2001 Incentive Stock Plan as compensation for services as an independent director and qualified under Rule 16b-3(d). The value of the compensation was $25,000 and the number of shares granted was determined based on the fair market value per share of Enzon's common stock on July 1, 2004, which was $12.57. 663 of the shares will vest on July 1, 2005, July 1, 2006 and July 1, 2007, respectively, provided that Ms. Dixon still serves as a director of Enzon as of such date. Exhibit List 24. Power of Attorney /s/ Gary A. Smith (Attorney-in-fact) 2004-07-14 EX-24 2 d60072_dixon.htm POWER OF ATTORNEY Dixon

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Gary Arlen Smith and Kenneth J. Zuerblis, signing singly, the undersigned’s true and lawful attorney-in-fact to:

(1)

execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Enzon Pharmaceuticals, Inc. (the “Company”), Forms 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

The undersigned hereby revokes any power of attorney previously granted by the undersigned to engage in the actions enumerated above.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 5th day of September, 2003.

	/s/ Rosina B. Dixon ————————————————
	Signature

	Rosina B. Dixon ————————————————
	Print Name

-----END PRIVACY-ENHANCED MESSAGE-----